Histone deacetylases (HDACs) are a group of enzymes that control histone deacetylation and bear potential to direct expression of large gene sets. We determined the effect of HDAC inhibitors (HDACi) on human monocytes and macrophages, with respect to their polarization, activation, and their capabilities of inducing endotoxin tolerance. To address the role for HDACs in macrophage polarization, we treated monocytes with HDAC3i, HDAC6i or pan-HDACi prior to polarization into M1 or M2 macrophages using IFNγ or IL-4 respectively. To study the HDAC inhibition effect on cytokine expression, macrophages were treated with HDACi prior to LPS-stimulation. TNFα, IL-6, and p40 were measured with ELISA, whereas modifications of Histone 3 and STAT1 were ...
Modifying the chromatin structure and interacting with non-histone proteins, histone deacetylases (H...
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epige...
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models but exacerbat...
Histone deacetylases (HDACs) are a group of enzymes that control histone deacetylation and bear pote...
Macrophages have central roles in danger detection, inflammation and host defense, and consequently,...
Macrophages, a key cellular component of inflammation, become functionally polarized in a signal- an...
Class I and II histone deacetylases (HDAC) are considered important regulators of immunity and infla...
Broad-spectrum inhibitors of histone deacetylases (HDACs) constrain Toll-like receptor (TLR)-inducib...
In this study, we investigated the role of individual class I histone deacetylases (HDACs) namely Hd...
Histone deacetylase (HDAC) inhibitors are small molecules inducing cell-cycle arrest, differentiatio...
<div><p>Inflammatory chronic pathologies are complex processes characterized by an imbalance between...
Histone deacetylase (HDAC) inhibitors (HDACi) are clinically approved anticancer drugs that have imp...
Monocytes and macrophages are key drivers in the pathogenesis of inflammatory diseases. Epigenetic t...
BackgroundAs important enzymes regulating acetylation, histone deacetylases (HDACs) participate in a...
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epige...
Modifying the chromatin structure and interacting with non-histone proteins, histone deacetylases (H...
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epige...
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models but exacerbat...
Histone deacetylases (HDACs) are a group of enzymes that control histone deacetylation and bear pote...
Macrophages have central roles in danger detection, inflammation and host defense, and consequently,...
Macrophages, a key cellular component of inflammation, become functionally polarized in a signal- an...
Class I and II histone deacetylases (HDAC) are considered important regulators of immunity and infla...
Broad-spectrum inhibitors of histone deacetylases (HDACs) constrain Toll-like receptor (TLR)-inducib...
In this study, we investigated the role of individual class I histone deacetylases (HDACs) namely Hd...
Histone deacetylase (HDAC) inhibitors are small molecules inducing cell-cycle arrest, differentiatio...
<div><p>Inflammatory chronic pathologies are complex processes characterized by an imbalance between...
Histone deacetylase (HDAC) inhibitors (HDACi) are clinically approved anticancer drugs that have imp...
Monocytes and macrophages are key drivers in the pathogenesis of inflammatory diseases. Epigenetic t...
BackgroundAs important enzymes regulating acetylation, histone deacetylases (HDACs) participate in a...
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epige...
Modifying the chromatin structure and interacting with non-histone proteins, histone deacetylases (H...
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epige...
Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models but exacerbat...